Endo, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

Marathon Asset Management and its affiliates have filed an amended Schedule 13G, reporting a beneficial ownership of 8.0% of Endo, Inc.'s common stock, indicating a passive investment.